DM
TARA icon

Deerfield Management’s Protara Therapeutics TARA Stock Holding History

Deerfield Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-782,670
Closed -$18.9M – 148
2020
Q4 		$18.9M Hold
782,670
– – 0.37% 73
2020
Q3 		$13.2M Buy
782,670
+350,000
+81% +$8.12M 0.32% 76
2020
Q2 		$12.7M Hold
432,670
– – 0.37% 70
2020
Q1 		$9.95M Buy
432,670
+381,945
+753% +$11.1M 0.32% 67
2019
Q4 		$832K Buy
50,725
+20,103
+66% +$231K 0.03% 74
2019
Q3 		$318K Hold
30,622
– – 0.01% 94
2019
Q2 		$510K Hold
30,622
– – 0.02% 96
2019
Q1 		$616K Hold
30,622
– – 0.02% 92
2018
Q4 		$2.78M Hold
30,622
– – 0.11% 82
2018
Q3 		$2.39M Hold
30,622
– – 0.09% 96
2018
Q2 		$3M Hold
30,622
– – 0.11% 105
2018
Q1 		$3.06M Hold
30,622
– – 0.11% 103
2017
Q4 		$2.33M Hold
30,622
– – 0.09% 90
2017
Q3 		$2.45M Hold
30,622
– – 0.11% 87
2017
Q2 		$1.87M Sell
30,622
-2,693
-8% -$151K 0.1% 80
2017
Q1 		$2.33M Hold
33,315
– – 0.09% 99
2016
Q4 		$2.53M Sell
33,315
-5,947
-15% -$1.88M 0.1% 87
2016
Q3 		$14.7M Buy
39,262
+461
+1% +$162K 0.68% 43
2016
Q2 		$12.5M Buy
38,801
+7,167
+23% +$2.14M 0.49% 55
2016
Q1 		$9.79M Hold
31,634
– – 0.42% 56
2015
Q4 		$19.6M Hold
31,634
– – 0.8% 44
2015
Q3 		$17.6M Hold
31,634
– – 0.68% 54
2015
Q2 		$22.6M Hold
31,634
– – 0.75% 48
2015
Q1 		$14.7M Hold
31,634
– – 0.48% 51
2014
Q4 		$13.2M Buy
+31,634
New +$12.8M 0.47% 53

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management's TARA Position: Q1 2021 in Review

Deerfield Management sold out of Protara Therapeutics (TARA) in Q1 2021, closing a stake of 782,670 shares — an estimated $18.9M sold.

Deerfield Management first reported a position in TARA in Q4 2014 and held it in 25 quarters. The position peaked at $22.6M in Q2 2015. 49 funds tracked by Wall St. Rank hold TARA as of Q1 2021.

  • Deerfield Management reported no remaining Protara Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Deerfield Management sold 782,670 Protara Therapeutics shares in Q1 2021, an estimated $18.9M.
  • Deerfield Management first reported a position in Protara Therapeutics in Q4 2014 and held it in 25 quarters.
  • Deerfield Management's Protara Therapeutics position peaked at $22.6M in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2021.

Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.